Genetic interactions among Idd3, Idd5.1, Idd5.2, and Idd5.3 protective loci in the nonobese diabetic mouse model of type 1 diabetes. 2013

Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, CA 92037, USA.

In the NOD mouse model of type 1 diabetes, insulin-dependent diabetes (Idd) loci control the development of insulitis and diabetes. Independently, protective alleles of Idd3/Il2 or Idd5 are able to partially protect congenic NOD mice from insulitis and diabetes, and to partially tolerize islet-specific CD8(+) T cells. However, when the two regions are combined, mice are almost completely protected, strongly suggesting the existence of genetic interactions between the two loci. Idd5 contains at least three protective subregions/causative gene candidates, Idd5.1/Ctla4, Idd5.2/Slc11a1, and Idd5.3/Acadl, yet it is unknown which of them interacts with Idd3/Il2. Through the use of a series of novel congenic strains containing the Idd3/Il2 region and different combinations of Idd5 subregion(s), we defined these genetic interactions. The combination of Idd3/Il2 and Idd5.3/Acadl was able to provide nearly complete protection from type 1 diabetes, but all three Idd5 subregions were required to protect from insulitis and fully restore self-tolerance. By backcrossing a Slc11a1 knockout allele onto the NOD genetic background, we have demonstrated that Slc11a1 is responsible for the diabetes protection resulting from Idd5.2. We also used Slc11a1 knockout-SCID and Idd5.2-SCID mice to show that both loss-of-function alleles provide protection from insulitis when expressed on the SCID host alone. These results lend further support to the hypothesis that Slc11a1 is Idd5.2.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004843 Epistasis, Genetic A form of gene interaction whereby the expression of one gene interferes with or masks the expression of a different gene or genes. Genes whose expression interferes with or masks the effects of other genes are said to be epistatic to the effected genes. Genes whose expression is affected (blocked or masked) are hypostatic to the interfering genes. Deviation, Epistatic,Epistatic Deviation,Genes, Epistatic,Genes, Hypostatic,Epistases, Genetic,Gene-Gene Interaction, Epistatic,Gene-Gene Interactions, Epistatic,Genetic Epistases,Genetic Epistasis,Interaction Deviation,Non-Allelic Gene Interactions,Epistatic Gene,Epistatic Gene-Gene Interaction,Epistatic Gene-Gene Interactions,Epistatic Genes,Gene Gene Interaction, Epistatic,Gene Gene Interactions, Epistatic,Gene Interaction, Non-Allelic,Gene Interactions, Non-Allelic,Gene, Epistatic,Gene, Hypostatic,Hypostatic Gene,Hypostatic Genes,Interaction, Epistatic Gene-Gene,Interaction, Non-Allelic Gene,Interactions, Epistatic Gene-Gene,Interactions, Non-Allelic Gene,Non Allelic Gene Interactions,Non-Allelic Gene Interaction
D005260 Female Females
D005952 Glucose-6-Phosphatase An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9. Glucosephosphatase,Glucose 6-Phosphatase,Glucose-6-Phosphate Phosphohydrolase,Glucose 6 Phosphatase
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse

Related Publications

Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
February 2001, Mammalian genome : official journal of the International Mammalian Genome Society,
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
January 2020, Methods in molecular biology (Clifton, N.J.),
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
December 2007, Journal of immunology (Baltimore, Md. : 1950),
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
January 2001, Journal of diabetes and its complications,
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
April 2008, Experimental neurology,
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
June 2013, Journal of immunology (Baltimore, Md. : 1950),
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
September 2012, American journal of physiology. Heart and circulatory physiology,
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
May 2014, American journal of physiology. Renal physiology,
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
October 2009, Journal of immunology (Baltimore, Md. : 1950),
Xiaotian Lin, and Emma E Hamilton-Williams, and Daniel B Rainbow, and Kara M Hunter, and Yang D Dai, and Jocelyn Cheung, and Laurence B Peterson, and Linda S Wicker, and Linda A Sherman
January 2007, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!